Table 1.
Demographic characteristics distribution regarding statins use of a chronic kidney disease population in Taiwan.
| All CKD | Statin User | Non-Statin User | |||||
|---|---|---|---|---|---|---|---|
| (N = 67,001) | (N = 17,634) | (N = 49,367) | |||||
| Variable | No. | % | No. | % | No. | % | p Value |
| Sarcopenia | |||||||
| Over all Sarcopenia | 2407 | 3.59 | 547 | 3.10 | 1860 | 3.77 | <0.0001 |
| Dialysis | 404 | 0.60 | 84 | 0.48 | 320 | 0.65 | 0.0114 |
| Age of CKD onset † | <0.0001 | ||||||
| <45 | 12,777 | 19.07 | 2157 | 12.23 | 10,620 | 21.51 | |
| 45–65 | 24,308 | 36.28 | 8550 | 48.49 | 15,758 | 31.92 | |
| >65 | 29,916 | 44.65 | 6927 | 39.28 | 22,989 | 46.57 | |
| Med(IQR) | 62.2 (48.70–73.50) | 61.1 (51.70–70.00) | 62.9 (47.30–74.90) | ||||
| Mean ± SD | 60.50 ± 16.70 | 60.30 ± 13.00 | 60.50 ± 17.80 | ||||
| Male sex | 37,215 | 55.54 | 8839 | 50.12 | 28,376 | 57.48 | <0.0001 |
| Monthly income †, NT$ | <0.0001 | ||||||
| 0 | 21,533 | 32.17 | 6593 | 37.39 | 14,960 | 30.30 | |
| 1–15,840 | 14,152 | 21.12 | 3490 | 19.79 | 10,662 | 21.60 | |
| 15,841–25,000 | 20,756 | 30.98 | 4915 | 27.87 | 15,841 | 32.09 | |
| ≧25,000 | 10,540 | 15.73 | 2636 | 14.95 | 7904 | 16.01 | |
| Urbanization level † | <0.0001 | ||||||
| I | 16,209 | 24.19 | 4730 | 26.82 | 11,479 | 23.25 | |
| II | 30,560 | 45.61 | 8112 | 46.00 | 22,448 | 45.47 | |
| III | 13,447 | 20.07 | 3265 | 18.52 | 10,182 | 20.63 | |
| IV | 6785 | 10.13 | 1527 | 8.66 | 5258 | 10.65 | |
| Follow time | |||||||
| Med(IQR) | 6.7(2.70-10.40) | 7.5 (4.20–10.70) | 6.30 (2.20-10.20) | ||||
| Mean ± SD | 6.70 ± 4.30 | 7.40 ± 3.90 | 6.40 ± 4.40 | ||||
CKD, chronic kidney disease; NT$, New Taiwan dollars; Med (IQR), median (interquartile range); 95% CI, 95% confidence interval. Urbanization level: I indicates the highest level of urbanization and IV the lowest. † χ² test.